The European Medicines Agency has allowed Eli Lilly to update the product label of its weight-loss drug Mounjaro to show it ...

They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...

Eli Lilly & Co.’s weight-loss and diabetes drug Mounjaro won’t be reclassified as a sleep apnea treatment in Europe, with ...

Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 496.78% and ...

Stock Editorial via Getty Images An expert panel of the EU drug regulator, the European Medicines Agency (EMA), has ...

Experts predict 2025's top plastic surgery itrends, from blepharoplasties, facelifts, and post weight-loss body procedures, to the buzzy field of regenerative aesthetics, ...

Recent studies show medications like Ozempic, originally designed for type 2 diabetes and weight loss, may help people ...

A man who ‘thought he was going to die’ after using the ‘King Kong’ of weight loss injections is warning others of the ...

On the other hand, the nature of its industry means that there will often be solid new reasons to be a bit more cautious ...

Losing weight can be a challenge for many. With so many variables present in everyday life, including stress, lack of sleep, ...

But Ozempic and Wegovy – and their newer cousin, Mounjaro – are expensive, and mostly only available on private prescription. For the past year, overweight Britons have been waiting for these ...